[Viral safety measures of plasma for transfusion and applicability in Spain].
Pereira
Arturo
A
Servicio de Hemoterapia y Hemostasia, Hospital Clínic, Barcelona, España. apereira@clinic.ub.es
D001779:Blood Coagulation Factors / Q000032:analysis; D001782:Blood Donors; D001803:Blood Transfusion / Q000331:legislation & jurisprudence / Q000592:standards*; D017326:Clinical Trials, Phase III as Topic; D003257:Consumer Product Safety; D005544:Forecasting; D006801:Humans; D008751:Methylene Blue / Q000494:pharmacology; D010949:Plasma / Q000187:drug effects / Q000821:virology*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012449:Safety; D013030:Spain; D065227:Transfusion Reaction; D014466:Ultraviolet Rays; D014766:Viremia / Q000517:prevention & control*; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission*; D014780:Viruses / Q000302:isolation & purification
D001779:Blood Coagulation Factors; D008751:Methylene Blue